首页 正文

S1PR3-G12-biased agonist ALESIA targets cancer metabolism and promotes glucose starvation

{{output}}
Metabolic activities are altered in cancer cells compared with those in normal cells, and the cancer-specific pathway becomes a potential therapeutic target. Higher cellular glucose consumption, which leads to lower glucose levels, is a hallmark of cancer cell... ...